Neurological Disorder Drugs In-Depth Industrial and Market studies - Europe Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024
 |
| Neurological Disorder Drugs |
Albany, New York, Mar 10, 2017
"Neurological
Disorder Drugs Market - Europe Industry Analysis, Size, Share,
Growth, Trends, and Forecast 2017 - 2024"
The Report covers current Industries Trends, Worldwide Analysis,
Global Forecast, Review, Share, Size, Growth, Effect.
Description-
– Europe
Neurological Disorder Drugs Market: Overview
This report on the neurological disorder drugs
market studies the current as well as future prospects of the market
in Europe. Health concern related to life threatening diseases are
the major concerns in the developed and developing countries of
Europe.
This
research report provides a detailed analysis of the neurological
disorder drugs market and helps understand the various driving
factors for the growth of the market. The market overview section
analyzes market dynamics and trends such as drivers, restraints and
opportunities that influence the current nature and future status of
the market. Market dynamics factors such as market attractiveness
analysis have also been explained in order to deliver a thorough
analysis of the overall competitive scenario of the Europe
neurological disorder drugs market.
– Europe Neurological Disorder Drugs
Market: Segmentation
The neurological disorder drugs market has been
segmented by disorder, by drug class, by distribution channel and by
countries. The disorder segment has been sub-segmented into Epilepsy,
Parkinson’s disease, Alzheimer’s disease, Multiple Sclerosis,
Cerebrovascular disease and others. The drug class has been segmented
into Anticholinergic, Antiepileptic, Antipsychotic, Analgesics,
Hypnotic & Sedative, Antihypertensive, Anticoagulants and others.
The distribution channel segment has been sub-segments into retail
pharmacy, hospital pharmacy and eCommerce.
– Europe Neurological Disorder Drugs
Market: Scope
The executive summary provides detailed insights
about the report and the market in general. This elaborate executive
summary provides a glimpse into the present scenario of the Europe
neurological disorder drugs market, which includes a market snapshot
that provides overall information of various segments and
sub-segments. The executive summary also provides overall information
and data analysis of the Europe neurological disorder drugs market
with respect to market segments based on disorder, drug class,
distribution channel as well as geographic regions.
The market for neurological disorder drugs has
been extensively analyzed based on their usefulness, effectiveness,
sales revenue and geographic presence. The market size and forecast
in terms of US$ Mn for each disorder, drug class, distribution
channel as well as geographic regions has been provided for the
period from 2017 to 2024. This report on the neurological disorder
drugs market also provides the compound annual growth rate (CAGR %)
for each market segment for the forecast period from 2017 to 2024,
considering 2015 as the base year.
– Europe Neurological Disorder Drugs
Market: Regional Outlook
Geographically, the neurological disorder drugs
market has been segmented into 10 major regions: Germany, France,
Italy, Spain, U.K., Russia, Switzerland, Netherlands, Poland and Rest
of Europe. The market size and forecast for each of these regions
have been provided for the period from 2017 to 2024, along with CAGR
(%) for the forecast period from 2017 to 2024. The research study
also incorporates the competitive scenario in these regions.
– Key Players Mentioned in this Report
are:
A list of recommendations has been provided for
new entrants as well as existing players to help establish a strong
presence in the market and increase market share. The report also
profiles major players in the neurological disorder drugs market
based on various attributes such as company overview, financial
overview, business strategies, product portfolio and recent
developments. Major players profiled in this report include Merck &
Co., Boehringer Ingelheim GmbH, Bayer AG, Astra Zeneca, F-Hoffmann-La
Roche Ltd., Teva Pharmaceutical Industries Ltd., Novartis AG, and
GlaxoSmithKline plc.
** The Europe Neurological Disorder Drugs market
is segmented as follows:
– Europe Neurological Disorder Drugs
Market Revenue, by Disorder
- Epilepsy
- Alzheimer’s disease
- Parkinson’s disease
- Multiple Sclerosis
- Cerebrovascular disease
- Others
– Europe Neurological Disorder Drugs
Market Revenue, by Drug Class
- Anticholinergic
- Antiepileptic
- Antipsychotic
- Hypnotic & Sedative
- Analgesics
- Antihypertensive
- Anticoagulants
- Others
– Europe Neurological Disorder Drugs
Market Revenue, by Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- eCommerce
– Europe Neurological Disorder Drugs
Market Revenue, by Geography
- Germany
- France
- Italy
- Spain
- UK
- Russia
- Switzerland
- Netherlands
- Poland
- Rest of Europe
Comments
Post a Comment